mofezolac has been researched along with Ileal Diseases in 1 studies
mofezolac: Cyclooxygenase 1 inhibitor; structure in first source; RN from Toxlit
Ileal Diseases: Pathological development in the ILEUM including the ILEOCECAL VALVE.
Excerpt | Relevance | Reference |
---|---|---|
" Toxic signs caused by N-22 administration, observed only in the 200 mg/kg group, were as follows: soiling around the mouth and/or nose, piloerection, anemia, diarrhea, emaciation and decreased spontaneous locomotor activity." | 1.28 | [Three-month oral subacute toxicity study of mofezolac (N-22) in rats]. ( Aoki, Y; Hashimoto, Y; Kiguchi, M; Kuwata, M; Okazaki, S; Shimpo, K; Takeuchi, M; Yamashita, K, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shimpo, K | 1 |
Takeuchi, M | 1 |
Okazaki, S | 1 |
Kiguchi, M | 1 |
Hashimoto, Y | 1 |
Aoki, Y | 1 |
Kuwata, M | 1 |
Yamashita, K | 1 |
1 other study available for mofezolac and Ileal Diseases
Article | Year |
---|---|
[Three-month oral subacute toxicity study of mofezolac (N-22) in rats].
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Chemical Analysis; Dri | 1990 |